Home/ Supplements/ Choline/ Fat Burner

Fat Burner

product on market Capsule Shredz Supplements Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Choline and Vitamin B5 support lipid metabolism and energy production, though evidence for their direct impact on fat loss is limited. The proprietary blend lacks transparency, making it difficult to assess the strength of the overall formula. Research on these specific ingredients generally shows moderate support for metabolic health.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Fat Burner
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg (4.35% DV)
Within RDA (0.2× RDA) 38 studies (A:1, B:7)
20 mg (400% DV)
4.0× RDA — above typical dose 2 studies — no high-quality reviews
SHREDZ(R) Proprietary Blend
1079 mg

Other Ingredients

Maltodextrin Magnesium Stearate Guggul Lipid extract Gelatin Titanium Dioxide FD&C YELLOW #5 FD&C YELLOW #6
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take oine (1) capsule in the morning followed by one (1) capsule preworkout.

Warnings & Precautions

WARNING: NEVER EXCEED RECOMMENDED DOSAGE

Not for use by persons under age 18.

Do not use if pregnant or nursing.

KEEP OUT OF REACH OF CHILDREN.

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Consult you physician prior to use if you are taking medication,including but not limited to, MAOI inhibitors, antidepressants, aspirin, non-steroidal anti-inflammatory drugs or products containing phenylephrine, ephedrine, pseudoephedrine, or other stimulants.

Do not use for more than 8 weeks.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heart beat, dizziness, severe headaches or shortness of breath.

Formulation Notes

Contains caffeine.

Additional Information

ALPHA

As individuals vary so may results from using this product. This product contains ingredients of international & domestic origin.

INSPECTED GOOD MANUFACTURING PRACTICES cGMP FACILITY

Metadata

Product Details

UPC / SKU8 11207 02153 4
DSLD Entry Date2014-04-25
Product TypeOther Combinations
FormCapsule
DSLD ID32023
Data Updated2026-04-11
Research

Research Evidence

28
Research Sources
47
Avg Quality
11
Clinical Trial
8
Rct
2
Guideline
2
Meta Analysis
2
Regulatory Source
1
Systematic Review
1
Openfda Safety
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024 PubMed DOI
B Integrating multi-structure covalent docking with machine-learning consensus scoring enhances potency ranking of human acetylcholinesterase inhibitors.
Guideline Briefings in bioinformatics 2026 PubMed DOI
B Evidence-based clinical practice guidelines for functional dyspepsia 2021.
Guideline Journal of gastroenterology 2022 PubMed DOI
B Scientific Opinion on health claims related to choline
Regulatory Source EFSA Journal 2011 DOI
C Effectiveness of nutritional interventions to prevent nonprogressive congenital and perinatal brain injuries: a systematic review and meta-analysis of randomized trials
Meta Analysis Nutrition reviews 2022 PubMed DOI
C Two methods for assessment of choline status in a randomized crossover study with varying dietary choline intake in people: isotope dilution MS of plasma and in vivo single-voxel magnetic resonance spectroscopy of liver.
Rct The American journal of clinical nutrition PubMed DOI
C Choline and betaine concentrations in plasma discriminate levels of dietary choline intake in healthy adults: analysis of a double-blind randomized crossover controlled feeding study.
Rct The American journal of clinical nutrition PubMed DOI
C Nutrient-based therapies for bipolar disorder: a systematic review
Systematic Review Psychotherapy and psychosomatics 2013 PubMed DOI
C The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
Rct The British journal of nutrition 2007 PubMed
C Differential metabolism of choline supplements in adult volunteers.
Rct European journal of nutrition PubMed DOI
View all evidence for Choline →
Compare

Similar Products

View all Choline products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.